Bcr-Abl Gene Translocation (Quantitative)
(BCR - ABL Quant.)
You need to provide
This test is for
What is BCR - ABL Quant.?
A quantitative Bcr- Abl oncogene assay is run to monitor the chromosome abnormality found in leukemia patients. Blood sample is carefully collected or bone marrow is aseptically collected for biopsy procedure and result evaluation.
Why is BCR - ABL Quant. done?
- To detect types of cancers such as Chronic Myelogenous Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL).
Cancer Genomic Tests from Star Biosciences is a solution that can help patients along their cancer journey. Star Biosciences sequences and analyzes a tumor’s genomic makeup to help oncologists understand the cancer-causing mutations within that individual patient’s sample. Watson for Genomics then compares those mutations against relevant medical literature. A Star Biosciences pathologist will review and validate the results and prepare a report to send back to the patient and his physician.